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ABSTRACT
Introduction Chronic post- surgical pain (CPSP) after 
lung or pleural surgery is a common complication and 
associated with a decrease in quality of life, long- term use 
of pain medication and substantial economic costs. An 
abundant number of primary prognostic factor studies are 
published each year, but findings are often inconsistent, 
methods heterogeneous and the methodological quality 
questionable. Systematic reviews and meta- analyses are 
therefore needed to summarise the evidence.
Methods and analysis The reporting of this protocol 
adheres to the Preferred Reporting Items for Systematic 
Review and Meta- Analysis Protocols (PRISMA- P) checklist. 
We will include retrospective and prospective studies 
with a follow- up of at least 3 months reporting patient- 
related factors and surgery- related factors for any adult 
population. Randomised controlled trials will be included 
if they report on prognostic factors for CPSP after lung or 
pleural surgery. We will exclude case series, case reports, 
literature reviews, studies that do not report results 
for lung or pleural surgery separately and studies that 
modified the treatment or prognostic factor based on pain 
during the observation period. MEDLINE, Scopus, Web of 
Science, Embase, Cochrane, CINAHL, Google Scholar and 
relevant literature reviews will be searched. Independent 
pairs of two reviewers will assess studies in two stages 
based on the PICOTS criteria. We will use the Quality in 
Prognostic Studies tool for the quality assessment and 
the CHARMS- PF checklist for the data extraction of the 
included studies. The analyses will all be conducted 
separately for each identified prognostic factor. We will 
analyse adjusted and unadjusted estimated measures 
separately. When possible, evidence will be summarised 
with a meta- analysis and otherwise narratively. We 
will quantify heterogeneity by calculating the Q and I2 
statistics. The heterogeneity will be further explored with 
meta- regression and subgroup analyses based on clinical 
knowledge. The quality of the evidence obtained will be 
evaluated according to the Grades of Recommendation 
Assessment, Development and Evaluation guideline 28.
Ethics and dissemination Ethical approval will not be 
necessary, as all data are already in the public domain. 
Results will be published in a peer- reviewed scientific 
journal.
PROSPERO registration number CRD42021227888.
INTRODUCTION
Lung or pleural surgery is performed for a 
variety of diseases or injuries, such as lung 
cancer, cancer of the pleura, lung emphy-
sema, lung transplantation and abscess after 
trauma or pleurodesis for recurrent pneu-
mothorces. The thorax can be surgically 
accessed with a regular thoracotomy or with 
less invasive video- assisted thoracic surgery 
(VATS). Thoracic surgery is associated with 
chronic post- surgical pain (CPSP), which is 
classified as any pain related to the surgery 
and persisting for 3 months or longer after 
surgery.1 2 CPSP often starts as a hard to 
control and acute post- surgical pain which 
later transitions into a persisting chronic 
pain.3 The pain is regularly localised at the 
chest wall and related to the area of surgery, 
but it can also be referred to a different area. 
It commonly increases with movement and 
often has a neuropathic component.4 5 CPSP 
has been observed in as many as 57% and 47% 
of the patients 3 and 6 months after thoracic 
surgery, respectively.6 Hence, thoracic 
surgery has the highest incidence of CPSP 
among all types of surgery.3 7 VATS is assumed 
Strengths and limitations of this study
 ► This systematic review and meta- analysis will be 
the first to systematically identify all prognostic fac-
tors for chronic post- surgical pain after lung or pleu-
ral surgery and to summarise the evidence.
 ► To ensure methodological quality, this systematic re-
view and meta- analysis will be conducted following 
the PROGnosis RESearch Strategy guide for prog-
nostic factor meta- analyses.
 ► Heterogeneity in the methods, the study populations 
and the reported outcomes of the included studies 
together with unexplained heterogeneity, will result 
in some level of uncertainty in our conclusions.
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to be less painful compared with a regular thoracotomy 
because it is less invasive, however, incidence and severity 
of CPSP have been reported to be similar.8 CPSP after 
thoracic surgery has been associated with a lower overall 
quality of life,9–13 and chronic pain is associated with an 
increased utilisation of healthcare, increased absenteeism 
and decreased work- related effectiveness.14–16 The direct 
health- related costs of chronic pain have been reported 
to be US$11 846 annually,17 and the indirect work- related 
costs have been reported to be US$29 617 annually.17 
The burden of CPSP for cancer survivors is also increas-
ingly recognised, given the progress that has been made 
in cancer treatment.18 Furthermore, CPSP often results 
in the long- term use of pain medication, particularly 
opioids, which contributes to overuse, misuse and addic-
tion of opioids,19–21 and thoracic surgery as an indepen-
dent factor has also been associated with prolonged 
postoperative opioid use.22 Thus, CPSP has significant 
health and economic related consequences and is a prob-
lematic complication. Evidence for prognostic factors can 
contribute to improved clinical decision- making and indi-
vidualised risk prediction by healthcare providers. A prog-
nostic factor is defined as any variable affecting the risk of 
a particular health outcome and should be evaluated in a 
representative sample of patients assembled at the same 
time point in the course of their disease.23 24 It can also 
contribute to the development of treatment strategies 
by identifying modifiable prognostic factors as targets.25 
This systematic review and meta- analysis will focus on all 
relevant reported prognostic factors for CPSP after lung 
or pleural surgery. There are two main categories we are 
interested in: Patient- related factors and surgery- related 
factors. A great number of primary prognostic factor 
studies are being published each year, however, they are 
often methodologically poor, their findings inconsistent 
and the methods heterogeneous.23 Therefore, system-
atic reviews and meta- analyses are needed to summarise 
the evidence.23 26 Other systematic reviews have been 
done regarding the incidence, severity and therapeutic 
interventions of chronic pain after thoracic surgery.6 27 28 
Another review has been done regarding the pathogenic 
mechanisms and strategies for prevention of chronic 
pain after thoracotomy.29 To our knowledge, a systematic 
review and meta- analysis regarding prognostic factors 
for CPSP after lung or pleural surgery has not yet been 
performed.
OBJECTIVES
Our main goal is to carry out a systematic overview of the 
evidence regarding prognostic factors for CPSP after lung 
or pleural surgery. Our objectives are to identify, describe 
and appraise all studies reporting prognostic factors for 
CPSP after lung or pleural surgery, and summarise the 
evidence for each prognostic factor, either quantitatively 
with a meta- analysis or qualitatively by describing the 
evidence as a narrative, as appropriate.
METHODS AND ANALYSIS
The reporting of this protocol adheres to the Preferred 
Reporting Items for Systematic Review and Meta- Analysis 
Protocols (PRISMA- P) checklist.30 31 It has been registered 
at the International Prospective Register of Systematic 
Reviews. For the project design we used guidance from 
the PROGnosis RESearch Strategy group, and specifically 
the guide for systematic reviews and meta- analyses for 
prognostic factor studies.26 The results of the systematic 
review will be reported following the PRISMA checklist.32
Study eligibility
We will include retrospective and prospective studies 
naming and evaluating a prognostic factor relating to 
chronic pain following lung or pleural surgery with at 
least 3 months of follow- up. Randomised controlled trials 
will be included if they report on prognostic factors for 
chronic pain after lung or pleural surgery. Case series, 
case studies, literature reviews, studies that do not report 
results for lung or pleural surgery separately and studies 
that modified the treatment or prognostic factor based 
on pain during the observation period will be excluded. 
We will use the PICOTS system as selection criteria for 
studies with the appropriate study type. (table 1). The 
PICOTS system is an updated modification for prognostic 
studies of the traditional PICO system, incorporating 
‘timing (T)’ and ‘setting (S)’.33 34 Timing includes at what 
time points the prognostic factors are being measured 
and setting includes the intended setting, such as primary 
or secondary care.26
Search strategy
We will search key health and medical databases 
(MEDLINE, Scopus, Web of Science, Embase, Cochrane, 
CINAHL and Google Scholar) for peer- reviewed literature 
Table 1 Summary table of the PICOTS used as selection 
criteria
Population
Any population of adult participants (18 
years or older) who have had any type of 




Pre- identified prognostic factors: 
Preoperative pain, postoperative pain, 
pain catastrophising score, age, gender, 
body mass index, diabetes mellitus, 
exercise tolerance, malignant diseases, 
chemotherapy, radiation therapy, surgery 
duration, anaesthesia technique and surgical 
technique. Any newly identified prognostic 




Because we will systematically identify 
all prognostic factors and summarise the 
evidence, no comparator prognostic factors 
are involved.
Outcome Chronic post- surgical pain as outcome.
Timing Follow- up of 3 months or more.
Setting Any healthcare setting.
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from inception of each database until most- recent avail-
able study on the date of conducting our final search. 
Screening of studies will start as soon as possible, and we 
aim that the last search date will not be longer than 12 
months from the publication date of the final review.
The systematic search will be built by an experienced 
information scientist and will be adapted to fit each 
information source.35 The reporting and retrieval of 
prognostic factors is generally known to be poor, with no 
specialised filters available. Hence a broad search will be 
employed using the most recent prognostic strategies, 
offering a high sensitivity at the cost of a lower speci-
ficity.36 We will use no restrictions on language, study 
status or time of publication. If translation is necessary, we 
will ask a colleague who is fluent in that language to trans-
late. When this is not possible, we will use the Cochrane 
task exchange service or Google Translate.37 The search 
strategy is included in online supplemental file 1, with the 
adaptations for each database. Because of potential limita-
tions of the electronic search strategy, we will supplement 
our search with reference searches of relevant literature 
studies.
Study screening
Independent pairs of two reviewers will assess studies in 
two stages based on the inclusion and exclusion criteria. 
They will screen studies in stage one on title and abstract 
and in stage two on the full text. Differences will be 
resolved through either a consensus meeting or consulta-
tion of a third reviewer in both selection phases. We will 
use the PRISMA flowchart to display the study selection 
process, including the exclusion reasons of non- eligible 
studies.32 Studies retrieved from the searches will be 
stored and screened in EndNote V.X9.38 The excluded 
studies will be stored in EndNote subgroups for each 
exclusion reason. The data that will be extracted from 
eligible studies will be stored and managed in Microsoft 
Excel V.16.43.
Data extraction
For the data collection process we will use the standardised 
CHARMS- PF checklist,26 which is based on the CHARMS 
checklist,34 but adjusted for prognostic factor studies. It 
has nine domains, covering everything needed to reli-
ably pool data: source of data, participants, outcomes 
to be predicted, prognostic factors, sample size, missing 
data, analysis, results and interpretation and discussion. 
Specific attention will be paid to the following data items: 
Reported factors of prognostic interest, definition and 
measurement of outcomes, adjusted and unadjusted 
outcomes, adjustment factors, regression methods and 
timing. When multiple follow- up time points are available, 
we will use a time point of at least 3 months that is closest 
to 3 months. If only the mean follow- up or the range of 
follow- up is reported, it needs to be at least 3 months. Any 
additional information deemed necessary will be added 
in a bespoke Excel data extraction file. If information in 
a study is missing or unclear, the primary study authors 
will be contacted with the request to provide additional 
information. We will consider the study with the biggest 
sample size or the most recent, as appropriate, as the 
most relevant one when there are multiple publications 
with the same or overlapping participant data.
Risk of bias in individual studies
The quality of included studies will be assessed by two 
independent reviewers with the Quality in Prognostic 
Studies tool.39 This tool contains six domains: Study 
participation, study attrition, prognostic factor measure-
ment, outcome measurement, study covariates and statis-
tical analysis and reporting. Each domain is rated as low, 
moderate or high risk of bias. If information in a study is 
missing or unclear, the authors will be contacted with the 
request to provide additional information. Differences 
between the two reviewers will be resolved through either 
a consensus meeting or consultation of a third reviewer.
Data synthesis
The characteristics of the identified prognostic factors will 
be summarised in a table. For the quantitative synthesis 
we will obtain ORs, risk ratios (RRs) and HRs as measures 
of association as reported in each included study. The 
mean difference will also be considered as an appropriate 
measure of association for continuous prognostic factors. 
Adjusted and unadjusted estimates for each factor will be 
considered and analysed separately. The OR, RR and HR 
will also be considered separately. A meta- analysis will be 
performed for each prognostic factor when reported by at 
least five studies with similar measures of association.26 40 
In cases where either the measure (OR, RR or HR), or 
its SE are not reported, where possible we will estimate 
them from any available data in the included study, such 
as confidence intervals, Kaplan- Meier curves, logrank test 
p values or other as appropriate.41–44 We will explore any 
differences between the reported and estimated measures 
through a sensitivity analysis. We will also include a sensi-
tivity analysis when there is heterogeneity between studies 
in how chronic pain is defined. For pooling the data, we 
will use the DerSimonian and Laird random effects model 
to account for expected between study heterogeneity.45 46 
We will include a 95% prediction interval in addition to 
the 95% CI for the pooled measures.46 Heterogeneity 
between studies will be assessed for each meta- analysis by 
visually inspecting forest plots and by calculating the Q 
statistic and the I2 statistic.47 We will perform a univari-
able meta- regression for each continuous prognostic 
factor reported by 10 or more studies. All analyses will be 
performed with the metafor package in the latest version 
of R and RStudio. When quantitative synthesis is not 
possible, we will summarise the evidence narratively.
Subgroup analyses
We will perform subgroup analyses where possible to 
further explore the heterogeneity. Based on clinical 
knowledge, the following subgroups will be investigated: 
Malignant diseases, regional anaesthesia (particularly 
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intercostal infiltration, single shot and continuous blocks 
and duration), neuropathic pain and surgical technique 
(particularly VATS or no VATS).
Publication bias
Funnel plots will be used to assess potential publication 
bias for factors of prognostic interest that are reported by 
10 or more studies.48 Funnel plots suffer from low power 
and this is more problematic for observational studies 
(as are studies of prognosis) where there is additionally 
increased heterogeneity. To statistically test the asym-
metry of the funnel plots we will use the Harbord test,49 
and any findings will be interpreted with caution.
Rating of evidence
The evidence and inferences will be evaluated according 
to the Grades of Recommendation Assessment, Devel-
opment, and Evaluation (GRADE) guidelines (GRADE 
guideline 28) for assessing the evidence from prognostic 
factors.50 It contains five domains: Risk of bias, inconsis-
tency, imprecision, indirectness and publication bias.
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SEH. MH and PMS provided the idea of the topic. MT and SEH contributed to the 
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(surg* OR operat* OR treat* OR resect* OR transplant*) NEAR/6 (pain* OR analgesi*)) OR ((post* 
NEAR/1 pain*)) OR pain-relief-after OR ((post-extraction OR postextraction OR amputat* OR 
mediastinoscopy OR sternotomy OR thoracoplasty OR thoracoscopy OR thoracostomy OR thoracotomy 
OR thoracocentesis OR thymectomy OR tracheostomy OR tracheotomy OR bronchoscopy OR 
pneumonolysis OR pneumonectomy OR esophagectomy OR oesophagectomy OR postmediastinoscop* 
OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR postthoracostom* OR 
postthoracotom* OR postthoracocentesis OR postthymectom* OR posttracheostom* OR 
posttracheotom* OR postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR 
postesophagectom* OR postoesophagectom* OR postlobectom*) NEAR/6 (pain* OR discomfort OR 
analgesi*))):ti,ab,kw) AND (('thorax surgery'/exp NOT 'heart surgery'/exp) OR 'lung tumor'/exp/dm_su 
OR (((thora* OR lung OR pulmonary OR esophag* OR oesophag* OR trachea* OR rib OR thym* OR chest 
OR pleura*) NEAR/6 (surg* OR operat* OR resect*)) OR mediastinoscop* OR sternotom* OR 
thoracoplast* OR thoracoscop* OR thoracostom* OR thoracotom* OR thoracocentesis OR thymectom* 
OR tracheostom* OR tracheotom* OR bronchoscop* OR pneumonolysis OR pneumonectom* OR 
esophagectom* OR oesophagectom* OR lobectom* OR postmediastinoscop* OR poststernotom* OR 
postthoracoplast* OR postthoracoscop* OR postthoracostom* OR postthoracotom* OR 
postthoracocentesis OR postthymectom* OR posttracheostom* OR posttracheotom* OR 
postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR postesophagectom* OR 
postoesophagectom* OR postlobectom* OR ((lung OR pulmonary OR thym*) NEAR/6 (transplant* OR 
graft*)) OR ((esophag* OR oesophag*) NEAR/6 (anastom* OR transect* OR dilat* OR 
reconstruct*))):ti,ab,kw) NOT [conference abstract]/lim NOT ([animals]/lim NOT [humans]/lim) 
Medline 
(Chronic Pain/ OR (((chronic* OR constant* OR continu* OR persist* OR longterm OR long-term OR 
longstanding OR long-standing OR longlasting OR long-lasting OR phantom) ADJ6 (pain* OR discomfort* 
OR complaint*)).ti,ab,kf)) AND (Pain, Postoperative/ OR (((postoperative OR posttreatment OR 
postsurg*) ADJ6 (pain* OR analgesi*)) OR ((post OR after OR follow*) ADJ3 (surg* OR operat* OR treat* 
OR resect* OR transplant*) ADJ6 (pain* OR analgesi*)) OR ((post* ADJ1 pain*)) OR pain-relief-after OR 
((post-extraction OR postextraction OR amputat* OR mediastinoscopy OR sternotomy OR thoracoplasty 
OR thoracoscopy OR thoracostomy OR thoracotomy OR thoracocentesis OR thymectomy OR 
tracheostomy OR tracheotomy OR bronchoscopy OR pneumonolysis OR pneumonectomy OR 
esophagectomy OR oesophagectomy OR postmediastinoscop* OR poststernotom* OR 
postthoracoplast* OR postthoracoscop* OR postthoracostom* OR postthoracotom* OR 
postthoracocentesis OR postthymectom* OR posttracheostom* OR posttracheotom* OR 
postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR postesophagectom* OR 
postoesophagectom* OR postlobectom*) ADJ6 (pain* OR discomfort OR analgesi*))).ti,ab,kf) AND 
(Thoracic Surgery/ OR (exp Thoracic Surgical Procedures/ NOT exp Cardiac Surgical Procedures/ ) OR 
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Lung Neoplasms/su OR (((thora* OR lung OR pulmonary OR esophag* OR oesophag* OR trachea* OR rib 
OR thym* OR chest OR pleura*) ADJ6 (surg* OR operat* OR resect*)) OR mediastinoscop* OR 
sternotom* OR thoracoplast* OR thoracoscop* OR thoracostom* OR thoracotom* OR thoracocentesis 
OR thymectom* OR tracheostom* OR tracheotom* OR bronchoscop* OR pneumonolysis OR 
pneumonectom* OR esophagectom* OR oesophagectom* OR lobectom* OR postmediastinoscop* OR 
poststernotom* OR postthoracoplast* OR postthoracoscop* OR postthoracostom* OR postthoracotom* 
OR postthoracocentesis OR postthymectom* OR posttracheostom* OR posttracheotom* OR 
postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR postesophagectom* OR 
postoesophagectom* OR postlobectom* OR ((lung OR pulmonary OR thym*) ADJ6 (transplant* OR 
graft*)) OR ((esophag* OR oesophag*) ADJ6 (anastom* OR transect* OR dilat* OR 
reconstruct*))).ti,ab,kf) NOT (exp animals/ NOT humans/) 
Web of Science 
TS=(((((chronic* OR constant* OR continu* OR persist* OR longterm OR long-term OR longstanding OR 
long-standing OR longlasting OR long-lasting OR phantom) NEAR/5 (pain* OR discomfort* OR 
complaint*)))) AND ((((postoperative OR posttreatment OR postsurg*) NEAR/5 (pain* OR analgesi*)) OR 
((post OR after OR follow*) NEAR/2 (surg* OR operat* OR treat* OR resect* OR transplant*) NEAR/5 
(pain* OR analgesi*)) OR ((post* NEAR/1 pain*)) OR pain-relief-after OR ((post-extraction OR 
postextraction OR amputat* OR mediastinoscopy OR sternotomy OR thoracoplasty OR thoracoscopy OR 
thoracostomy OR thoracotomy OR thoracocentesis OR thymectomy OR tracheostomy OR tracheotomy 
OR bronchoscopy OR pneumonolysis OR pneumonectomy OR esophagectomy OR oesophagectomy OR 
postmediastinoscop* OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR 
postthoracostom* OR postthoracotom* OR postthoracocentesis OR postthymectom* OR 
posttracheostom* OR posttracheotom* OR postbronchoscop* OR postpneumonolysis OR 
postpneumonectom* OR postesophagectom* OR postoesophagectom* OR postlobectom*) NEAR/5 
(pain* OR discomfort OR analgesi*)))) AND ((((thora* OR lung OR pulmonary OR esophag* OR 
oesophag* OR trachea* OR rib OR thym* OR chest OR pleura*) NEAR/5 (surg* OR operat* OR resect*)) 
OR mediastinoscop* OR sternotom* OR thoracoplast* OR thoracoscop* OR thoracostom* OR 
thoracotom* OR thoracocentesis OR thymectom* OR tracheostom* OR tracheotom* OR bronchoscop* 
OR pneumonolysis OR pneumonectom* OR esophagectom* OR oesophagectom* OR lobectom* OR 
postmediastinoscop* OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR 
postthoracostom* OR postthoracotom* OR postthoracocentesis OR postthymectom* OR 
posttracheostom* OR posttracheotom* OR postbronchoscop* OR postpneumonolysis OR 
postpneumonectom* OR postesophagectom* OR postoesophagectom* OR postlobectom* OR ((lung OR 
pulmonary OR thym*) NEAR/5 (transplant* OR graft*)) OR ((esophag* OR oesophag*) NEAR/5 
(anastom* OR transect* OR dilat* OR reconstruct*))))) AND DT=(article) 
Cochrane 
((((chronic* OR constant* OR continu* OR persist* OR longterm OR long NEXT term OR longstanding OR 
long NEXT standing OR longlasting OR long NEXT lasting OR phantom) NEAR/6 (pain* OR discomfort* OR 
complaint*)):ti,ab)) AND ((((postoperative OR posttreatment OR postsurg*) NEAR/6 (pain* OR 
analgesi*)) OR ((post OR after OR follow*) NEAR/3 (surg* OR operat* OR treat* OR resect* OR 
transplant*) NEAR/6 (pain* OR analgesi*)) OR ((post* NEAR/1 pain*)) OR pain NEXT relief NEXT after OR 
((post NEXT extraction OR postextraction OR amputat* OR mediastinoscopy OR sternotomy OR 
thoracoplasty OR thoracoscopy OR thoracostomy OR thoracotomy OR thoracocentesis OR thymectomy 
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OR tracheostomy OR tracheotomy OR bronchoscopy OR pneumonolysis OR pneumonectomy OR 
esophagectomy OR oesophagectomy OR postmediastinoscop* OR poststernotom* OR 
postthoracoplast* OR postthoracoscop* OR postthoracostom* OR postthoracotom* OR 
postthoracocentesis OR postthymectom* OR posttracheostom* OR posttracheotom* OR 
postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR postesophagectom* OR 
postoesophagectom* OR postlobectom*) NEAR/6 (pain* OR discomfort OR analgesi*))):ti,ab) AND 
((((thora* OR lung OR pulmonary OR esophag* OR oesophag* OR trachea* OR rib OR thym* OR chest 
OR pleura*) NEAR/6 (surg* OR operat* OR resect*)) OR mediastinoscop* OR sternotom* OR 
thoracoplast* OR thoracoscop* OR thoracostom* OR thoracotom* OR thoracocentesis OR thymectom* 
OR tracheostom* OR tracheotom* OR bronchoscop* OR pneumonolysis OR pneumonectom* OR 
esophagectom* OR oesophagectom* OR lobectom* OR postmediastinoscop* OR poststernotom* OR 
postthoracoplast* OR postthoracoscop* OR postthoracostom* OR postthoracotom* OR 
postthoracocentesis OR postthymectom* OR posttracheostom* OR posttracheotom* OR 
postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR postesophagectom* OR 
postoesophagectom* OR postlobectom* OR ((lung OR pulmonary OR thym*) NEAR/6 (transplant* OR 
graft*)) OR ((esophag* OR oesophag*) NEAR/6 (anastom* OR transect* OR dilat* OR 
reconstruct*))):ti,ab)  
CINAHL 
(MH Chronic Pain OR TI(((chronic* OR constant* OR continu* OR persist* OR longterm OR long-term OR 
longstanding OR long-standing OR longlasting OR long-lasting OR phantom) N5 (pain* OR discomfort* 
OR complaint*))) OR AB(((chronic* OR constant* OR continu* OR persist* OR longterm OR long-term OR 
longstanding OR long-standing OR longlasting OR long-lasting OR phantom) N5 (pain* OR discomfort* 
OR complaint*)))) AND (MH Postoperative Pain OR TI(((postoperative OR posttreatment OR postsurg*) 
N5 (pain* OR analgesi*)) OR ((post OR after OR follow*) N2 (surg* OR operat* OR treat* OR resect* OR 
transplant*) N5 (pain* OR analgesi*)) OR ((post* N1 pain*)) OR pain-relief-after OR ((post-extraction OR 
postextraction OR amputat* OR mediastinoscopy OR sternotomy OR thoracoplasty OR thoracoscopy OR 
thoracostomy OR thoracotomy OR thoracocentesis OR thymectomy OR tracheostomy OR tracheotomy 
OR bronchoscopy OR pneumonolysis OR pneumonectomy OR esophagectomy OR oesophagectomy OR 
postmediastinoscop* OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR 
postthoracostom* OR postthoracotom* OR postthoracocentesis OR postthymectom* OR 
posttracheostom* OR posttracheotom* OR postbronchoscop* OR postpneumonolysis OR 
postpneumonectom* OR postesophagectom* OR postoesophagectom* OR postlobectom*) N5 (pain* 
OR discomfort OR analgesi*))) OR AB(((postoperative OR posttreatment OR postsurg*) N5 (pain* OR 
analgesi*)) OR ((post OR after OR follow*) N2 (surg* OR operat* OR treat* OR resect* OR transplant*) 
N5 (pain* OR analgesi*)) OR ((post* N1 pain*)) OR pain-relief-after OR ((post-extraction OR 
postextraction OR amputat* OR mediastinoscopy OR sternotomy OR thoracoplasty OR thoracoscopy OR 
thoracostomy OR thoracotomy OR thoracocentesis OR thymectomy OR tracheostomy OR tracheotomy 
OR bronchoscopy OR pneumonolysis OR pneumonectomy OR esophagectomy OR oesophagectomy OR 
postmediastinoscop* OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR 
postthoracostom* OR postthoracotom* OR postthoracocentesis OR postthymectom* OR 
posttracheostom* OR posttracheotom* OR postbronchoscop* OR postpneumonolysis OR 
postpneumonectom* OR postesophagectom* OR postoesophagectom* OR postlobectom*) N5 (pain* 
OR discomfort OR analgesi*)))) AND ((MH "Thoracic Surgery+" NOT MH "Heart Surgery+" ) OR 
TI(((thora* OR lung OR pulmonary OR esophag* OR oesophag* OR trachea* OR rib OR thym* OR chest 
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OR pleura*) N5 (surg* OR operat* OR resect*)) OR mediastinoscop* OR sternotom* OR thoracoplast* 
OR thoracoscop* OR thoracostom* OR thoracotom* OR thoracocentesis OR thymectom* OR 
tracheostom* OR tracheotom* OR bronchoscop* OR pneumonolysis OR pneumonectom* OR 
esophagectom* OR oesophagectom* OR lobectom* OR postmediastinoscop* OR poststernotom* OR 
postthoracoplast* OR postthoracoscop* OR postthoracostom* OR postthoracotom* OR 
postthoracocentesis OR postthymectom* OR posttracheostom* OR posttracheotom* OR 
postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR postesophagectom* OR 
postoesophagectom* OR postlobectom* OR ((lung OR pulmonary OR thym*) N5 (transplant* OR graft*)) 
OR ((esophag* OR oesophag*) N5 (anastom* OR transect* OR dilat* OR reconstruct*))) OR AB(((thora* 
OR lung OR pulmonary OR esophag* OR oesophag* OR trachea* OR rib OR thym* OR chest OR pleura*) 
N5 (surg* OR operat* OR resect*)) OR mediastinoscop* OR sternotom* OR thoracoplast* OR 
thoracoscop* OR thoracostom* OR thoracotom* OR thoracocentesis OR thymectom* OR tracheostom* 
OR tracheotom* OR bronchoscop* OR pneumonolysis OR pneumonectom* OR esophagectom* OR 
oesophagectom* OR lobectom* OR postmediastinoscop* OR poststernotom* OR postthoracoplast* OR 
postthoracoscop* OR postthoracostom* OR postthoracotom* OR postthoracocentesis OR 
postthymectom* OR posttracheostom* OR posttracheotom* OR postbronchoscop* OR 
postpneumonolysis OR postpneumonectom* OR postesophagectom* OR postoesophagectom* OR 
postlobectom* OR ((lung OR pulmonary OR thym*) N5 (transplant* OR graft*)) OR ((esophag* OR 
oesophag*) N5 (anastom* OR transect* OR dilat* OR reconstruct*)))) NOT (MH animals+ NOT MH 
humans) 
Scopus 
TITLE-ABS-KEY(((((chronic* OR constant* OR continu* OR persist* OR longterm OR long-term OR 
longstanding OR long-standing OR longlasting OR long-lasting OR phantom) W/5 (pain* OR discomfort* 
OR complaint*)))) AND ((((postoperative OR posttreatment OR postsurg*) W/5 (pain* OR analgesi*)) OR 
((post OR after OR follow*) W/2 (surg* OR operat* OR treat* OR resect* OR transplant*) W/5 (pain* OR 
analgesi*)) OR ((post* W/1 pain*)) OR pain-relief-after OR ((post-extraction OR postextraction OR 
amputat* OR mediastinoscopy OR sternotomy OR thoracoplasty OR thoracoscopy OR thoracostomy OR 
thoracotomy OR thoracocentesis OR thymectomy OR tracheostomy OR tracheotomy OR bronchoscopy 
OR pneumonolysis OR pneumonectomy OR esophagectomy OR oesophagectomy OR 
postmediastinoscop* OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR 
postthoracostom* OR postthoracotom* OR postthoracocentesis OR postthymectom* OR 
posttracheostom* OR posttracheotom* OR postbronchoscop* OR postpneumonolysis OR 
postpneumonectom* OR postesophagectom* OR postoesophagectom* OR postlobectom*) W/5 (pain* 
OR discomfort OR analgesi*)))) AND ((((thora* OR lung OR pulmonary OR esophag* OR oesophag* OR 
trachea* OR rib OR thym* OR chest OR pleura*) W/5 (surg* OR operat* OR resect*)) OR 
mediastinoscop* OR sternotom* OR thoracoplast* OR thoracoscop* OR thoracostom* OR thoracotom* 
OR thoracocentesis OR thymectom* OR tracheostom* OR tracheotom* OR bronchoscop* OR 
pneumonolysis OR pneumonectom* OR esophagectom* OR oesophagectom* OR lobectom* OR 
postmediastinoscop* OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR 
postthoracostom* OR postthoracotom* OR postthoracocentesis OR postthymectom* OR 
posttracheostom* OR posttracheotom* OR postbronchoscop* OR postpneumonolysis OR 
postpneumonectom* OR postesophagectom* OR postoesophagectom* OR postlobectom* OR ((lung OR 
pulmonary OR thym*) W/5 (transplant* OR graft*)) OR ((esophag* OR oesophag*) W/5 (anastom* OR 
transect* OR dilat* OR reconstruct*)))))  
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Google scholar 
"chronic|constant|persisting|longterm|longstanding|longlasting|phantom pain" 
"postoperative|postsurgical pain" "thorax|thoracic  surgery|operation" 
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